Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
09/2003
09/24/2003EP1345891A1 Glucagon antagonist/inverse agonist
09/24/2003EP1345890A1 Glucagon antagonists/inverse agonists
09/24/2003CN1444561A Acetamide derivatives and use thereof as inhibitors of coagulation factors XA and VIIA
09/24/2003CN1444477A Thrombopoietin mimetics
09/24/2003CN1121906C Long lived homogenoux oxidation catalyst
09/23/2003US6624309 Administering 4-heterocyclicbenzamide derivative
09/23/2003US6624172 Imidazonaphthyridines
09/23/2003US6624121 Exemplified by 2-cyano-3-cyclopropyl-1-(3-((4-cyclopropyl-4,5-dihydro-5-oxo-1H-tetrazol-1 -yl)methyl)-2, 4-dichlorophenyl)propan-1,3-dione
09/18/2003WO2003076417A2 Oxo-azabicyclic compounds
09/18/2003WO2003076416A1 Oxo azabicyclic compounds
09/18/2003WO2003053368A3 Chalcone derivatives and their use to treat diseases
09/18/2003US20030176329 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
09/18/2003CA2478706A1 Oxo-azabicyclic compounds
09/17/2003EP1343770A2 Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, production and use thereof
09/17/2003EP1135376B1 Method of producing cyclene
09/17/2003EP0643704B1 Tetrazolylphenylboronic acid intermediates for the synthesis of aii receptor antagonists
09/17/2003CN1443176A Valsartan salts
09/17/2003CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors
09/12/2003WO2003074523A2 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates
09/12/2003WO2003074008A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2003073986A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2477449A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2477423A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/11/2003US20030171414 Valsartan; hypotensive agents, cardiovascular disorders, anticholesterol agents, antilipemic agents
09/11/2003US20030168630 Macrocyclic tetraamido ligands as bleaching catalysts and synthesis thereof
09/10/2003EP1032557B1 Method for preparing bromomethyl-biphenyl derivatives
09/10/2003EP0993306B1 Perfluoroalkylated oligomer compounds, process for preparing the same and their use in nmr diagnosis
09/10/2003CN1441791A 四唑衍生物 Tetrazole derivative
09/09/2003US6617352 Compounds and methods for the inhibition of the expression of VCAM-1
09/04/2003WO2003072535A2 Substituted hydroxyethylamines
09/04/2003US20030166694 Glycinamides
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166687 Alpha-hydroxy,-amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003CA2477607A1 Substituted hydroxyethylamines
09/03/2003EP1339663A2 Naphthalene derivatives
09/03/2003EP0977741B1 Substituted phenyl derivatives, their preparation and use
09/03/2003CN1440394A Novel tetrazole derivatives
09/03/2003CN1440298A Medical aerosol formulation
09/03/2003CN1120159C Intermediate for preparing 1,4-disubstituted tetraazole-quinolinone
08/2003
08/27/2003EP1337539A2 Linkable sialyl lewis x analogs
08/27/2003EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials
08/26/2003US6610883 Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
08/26/2003US6610854 Reacting (Z)-5-Fluoro-2-methyl-(4-pyridylidene)-3-(N-benzyl) indenylacetamide with hydrochloric acid to produce (Z)-5-fluoro-2-methyl-(4-pyridylidene)-3-(N-benzyl)indenylacetamide hydrochloride
08/26/2003US6610743 Bicyclic metabotropic glutamate receptor ligands
08/26/2003US6610702 Ammonium salts of inositol hexaphosphate, and uses thereof
08/26/2003US6610156 Nitramines are recovered from aluminized energetic materials without recrystallizing and in which there is no need for the use of either liquid ammonia under increased pressure or hazardous organic solvents that are volatile and/or flammable
08/21/2003US20030158393 Radiolabeled chelation compounds used in pharmaceuticals for diagnostic and therapeutic purposes
08/21/2003US20030158256 (Arylaminoaceamido)acetonitrile derivatives
08/21/2003US20030158155 Mmp-12 inhibitors
08/20/2003EP1336600A2 Dimer-selective RXR modulators and methods for their use
08/20/2003EP1150944B1 N2-phenylamidine derivatives
08/20/2003CN1437581A Glucagon antagonists/inverse agonists
08/20/2003CN1437468A Halogentated 2-amino-5.6-heptenoic aicd derivatives useful as nitric oxide synthase inhibitors
08/20/2003CN1118462C Substituted phenyl derivatives, producing method and use thereof
08/19/2003US6608227 Benzylcycloalkyl amines as modulators of chemokine receptor activity
08/14/2003WO2003066673A1 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
08/14/2003WO2003066646A2 Macrocyclic module compositions
08/14/2003WO2003066607A1 Novel tetrazole derivative useful as herbicides
08/14/2003WO2003066606A1 Salts of valsartan
08/14/2003WO2003066577A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
08/14/2003WO2003066565A1 Deuterated biphenyl derivatives
08/14/2003WO2003065789A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
08/14/2003WO2003024955A3 Small molecule inhibitors of caspases
08/14/2003US20030153508 Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient
08/14/2003US20030153465 Substituted aryl ketones
08/14/2003CA2776902A1 Salts of valsartan
08/14/2003CA2475646A1 Macrocyclic module compositions
08/14/2003CA2475609A1 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
08/14/2003CA2475336A1 Novel tetrazole derivative useful as herbicides
08/14/2003CA2474424A1 Salts of valsartan
08/14/2003CA2473778A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
08/13/2003EP1335250A1 Electrophotographic organophotoreceptors with novel charge transport materials
08/13/2003EP1334083A2 1,4-disubstituted benzenes as insecticides
08/07/2003WO2003064369A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/07/2003WO2003063576A2 Arylsulfonamidobenzylic compounds
08/07/2003US20030149107 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
08/07/2003US20030149015 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives
08/07/2003US20030145923 Propellant for gas generators
08/07/2003CA2474433A1 Arylsulfonamidobenzylic compounds
08/07/2003CA2473162A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/06/2003EP0711762B1 Process for producing tetrazole compounds
08/06/2003CN1117094C Processfor preparing 5H, 96H-2a, 4a, 7,9a-actahydrotetraaze-cycloocta (cd) pentalene
08/06/2003CN1117088C Process for prepn. of 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acidand derivatives thereof
08/05/2003US6602914 Treatment of a disease that is mediated by the expression or suppression of a redox sensitive gene, for example MCP-1, IL-6 and thrombin receptor; antiinflammatory agents; cardio-vascular disorders; atherosclerosis; immunology
08/05/2003US6602895 Inhibitors of factor Xa with a neutral P1 specificity group
08/05/2003CA2275827C Method for treating glaucoma
07/2003
07/31/2003WO2003062248A2 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists
07/31/2003WO2002030863A3 Ether compounds and compositions for cholesterol management and related uses
07/31/2003US20030144328 Compounds which inhibit leukocyte adhesion mediated by VLA-4
07/30/2003EP0986548B1 Production of mono and 1,7-bis-n-hydroxyalkyl-cyclene and lithium salt complexes
07/29/2003US6600043 Carboxylic acid derivatives, their preparation and use
07/29/2003CA2134092C Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies
07/24/2003US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders
07/24/2003US20030139379 Autoimmune disease, osteoporosis, rheumatic diseases, skin disorders
07/23/2003EP0888278B1 Antidiabetic agents
07/22/2003US6596741 Compounds of formula I exhibit activity as serotonin, norepinephrine, and dopamine reuptake inhibitors and can be used in the treatment of central nervous system and other disorders.
07/22/2003US6596716 2-propane-sulphonamide derivatives
07/17/2003US20030135063 Especially Type II diabetes; stimulating the kinase activity of the insulin receptor; activating the insulin receptor
07/16/2003EP1326822A2 Ketone compounds and compositions for cholesterol management and related uses
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 97